| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Silenseed |
| Recipient: An Immediate Family Member |
| Company: CytomX Therapeutics |
| Recipient: An Immediate Family Member |
| Company: SOBI |
| Recipient: An Immediate Family Member |
| Company: Cend |
| Recipient: An Immediate Family Member |
| Company: Celgene |
| Recipient: An Immediate Family Member |
| Company: Eli Lilly |
| Recipient: An Immediate Family Member |
| Company: Rafael |
| Recipient: An Immediate Family Member |
| Company: Sillajen |
| Recipient: You |
| Company: Bayer |
| Recipient: You |
| Company: Eisai |
| Recipient: You |
| Company: Ipsen |
| Recipient: You |
| Company: Merck Serono |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: BeiGene |
| Recipient: You |
| Company: Genoscience Pharma |
| Recipient: You |
| Company: RedHill Biopharma |
| Recipient: You |
| Company: twoXAR |
| Recipient: You |
| Company: Yiviva |
| Recipient: You |
| Company: Flatiron Health |
| Recipient: You |
| Company: Roche/Genentech |
| Recipient: You |
| Company: Autem |
| Recipient: You |
| Company: Berry Genomics |
| Recipient: You |
| Company: Incyte |
| Recipient: You |
| Company: TheraBionic |
| Recipient: You |
| Company: Vector |
| Recipient: You |
| Company: Helio |
| Recipient: You |
| Company: Alnylam |
| Recipient: You |
| Company: Adicet Bio |
| Recipient: You |
| Company: Exelixis |
| Recipient: You |
| Company: Legend Biotech |
| Recipient: You |
| Company: Nerviano |
| Recipient: You |
| Company: QED Therapeutics |
| Recipient: You |
| Company: Surface Oncology |
| Recipient: You |
| Company: Yiviva |
| Recipient: You |
| Company: SERVIER |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Bayer |
| Recipient: Your Institution |
| Company: AstraZeneca |
| Recipient: Your Institution |
| Company: Bristol-Myers Squibb |
| Recipient: Your Institution |
| Company: Incyte |
| Recipient: Your Institution |
| Company: Agios |
| Recipient: Your Institution |
| Company: Polaris |
| Recipient: Your Institution |
| Company: Puma Biotechnology |
| Recipient: Your Institution |
| Company: QED |
| Recipient: Your Institution |
| Company: Arcus |
| Recipient: Your Institution |
| Company: BioNtech |
| Recipient: Your Institution |
| Company: Celgene |
| Recipient: Your Institution |
| Company: Flatiron |
| Recipient: Your Institution |
| Company: Genentech/Roche |
| Recipient: Your Institution |
| Company: Genoscience |
| Recipient: Your Institution |
| Company: QED Therapeutics |
| Recipient: Your Institution |
| Company: Silenseed |
| Recipient: Your Institution |
| Company: Yiviva |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| Company: Polaris |
| Recipient: You |
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| not answered |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|